slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
230,221-230,250 of 319,975
74
The slide uses a heatmap to visualize synergy (green = yes, light green = no) across 6 drug combinations and 14 patient samples.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
75
Includes statistical significance markers (asterisks) and safety observation regarding body weight.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
76
Uses Bliss Independence Model for synergy calculation. Includes a heatmap of synergy across subtypes and dose-response curves for two specific models (DMS79 and H345).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
77
The heatmap displays AUC values for 16 patient samples across three treatments.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
78
The slide uses a two-column layout to contrast PK and Toxicology findings.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
79
MIDD = Model-informed Drug DevelopmentExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
80
The background features a stylized molecular structure, emphasizing the biotech/pharma context.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
81
The slide uses a three-column layout to summarize the value proposition of a drug candidate.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
82
The slide uses a biological pathway diagram to illustrate the mechanism of action.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
83
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
84
The slide uses a biological mechanism argument to establish a safety/efficacy advantage for the drug candidate '565.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
85
The slide uses a heatmap-style table to visualize performance against criteria, with a specific focus on UGT1A1 inhibition risk.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
86
The slide uses a linear process flow to explain a complex drug discovery workflow.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
87
The slide highlights the application of computational chemistry (molecular dynamics) to drug discovery, specifically focusing on binding site analysis.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
88
The slide presents preclinical efficacy data for a MALT1 inhibitor ('565) in combination with Ibrutinib.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
89
The slide uses dose-response curves to show IC50 and selectivity.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
90
The table uses a heatmap-style color coding (red/green) to indicate risk levels.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
91
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
92
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
93
This is a standard corporate contact/disclaimer slide.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
01
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
02
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
03
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a Gantt-style visualization to represent drug development stages.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations 1 hit
05
The slide uses a circular, iterative process flow to represent the R&D lifecycle.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations 1 hit
06
The chart uses a visual metaphor of shifting a curve to represent economic improvement in drug development.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · NeedLoop · Before After1 hit
07
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · NeedLoop · Before After1 hit
08
The slide uses a timeline-like axis to represent ranking improvement from a broad prompt to a precision prompt.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Loop · Before After1 hit
09
The slide uses a numbered process flow (1-4) mapped to a visual representation of an LLM interface.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Loop · Before After1 hit
10
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations 1 hit